TRVI Competitors & Alternatives
Compare Trevi Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRVI
Main Stock$14.78
Tradestie Score
60
Market Cap
$1.14B
Analyst Upside
+61.7%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.76
|
$2.02B | 44.1 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.83
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.39
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.02
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.96
|
$1.92B | - | 53 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.08
|
$1.90B | 421.3 | 67 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.40
|
$1.84B | - | 60 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.81
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.21
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$19.09
|
$1.78B | - | 58 | Compare |
More TRVI Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry